etoposide has been researched along with Duncan Disease in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 13 (54.17) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Don, AS; Martinez-Lamenca, C; Proia, RL; Roberts, E; Rosen, H; Webb, WR | 1 |
| Absalon, MJ; Breese, EH; Burns, KC; Lee, L; Mangino, JL; Mizukawa, B; Norris, RE; O'Brien, MM; Perentesis, JP; Phillips, CL; Pommert, L; Rubinstein, JD; Shah, R | 1 |
| Aggarwal, A; Catlett, JP; DeStefano, CB; Fitzpatrick, K; Malkovska, V; Rafei, H; Shenoy, A | 1 |
| Imadome, KI; Kanegane, H; Kawano, Y; Kodama, Y; Nakagawa, S; Nakazawa, Y; Nishikawa, T; Okamoto, Y; Saito, A; Yatsushiro, Y | 1 |
| Imashuku, S; Kubo, K; Kudo, N; Yachie, A | 1 |
| Fukayama, M; Koda, K; Tajima, S; Takanashi, Y | 1 |
| Gil, L; Komarnicki, M; Kozlowska-Skrzypczak, M; Mol, A; Poplawski, D; Styczynski, J | 1 |
| Coppo, P; Dartigues, P; Gorin, NC; Poujol-Robert, A; Serrate, C; Silva-Moreno, M; Sokol, H | 1 |
| Fujii, S; Kaneko, H; Matsui, Y; Miura, Y; Nakamura, C; Sugino, N; Tsudo, M; Wakasa, T; Watanabe, M | 1 |
| Byrne, J; Carter, GI; Craddock, CF; Cull, GM; Garg, M; Haynes, AP; Lui Yin, JA; Lush, RJ; Mahendra, P; Mufti, G; Pagliuca, A; Parker, JE; Potter, MN; Prentice, HG; Russell, NH | 1 |
| Berkow, RL; Hilliard, LM; Watts, RG | 1 |
| Anagnostopoulos, I; Hummel, MW; Jonas, S; Oertel, SH; Papp-Váry, M; Riess, HB | 1 |
| Koay, ES; Lau, LG; Liu, TC; Salto-Tellez, M; Tan, LK | 1 |
| Abboud, CN; Felgar, R; Komrokji, RS; Oliva, JL; Zand, M | 1 |
| Bader, P; Boppana, S; Dormann, S; Fisch, P; Goebel, H; Jung, A; Kontny, U; Niemeyer, C; Peters, A; Strahm, B; Werner, M | 1 |
| Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
| Arceci, RJ; Chen, AR; Colombani, P; Higman, MA; Schwartz, CL; Wharam, M; Williams, KM | 1 |
| Carr, TJ; Costanzo, MR; Fisher, RI; Mullen, GM; Swinnen, LJ | 1 |
| Schwinghammer, TL | 1 |
| Gadner, H; Panzer-Grümayer, ER; Peters, C; Pracher, E; Zoubek, A | 1 |
| Chen, RL; Cheng, AL; Su, IJ; Wang, CH | 1 |
| Barbui, T; Bassan, R; Chiodini, B; Cornelli, PE; Cortelazzo, S; Lerede, T; Zucchetti, M | 1 |
| Altés, A; Briones, J; Brunet, S; Cabezudo, E; López, R; Madoz, P; Martinez, C; Martino, R; Muñoz, L; Perea, G; Salar, A; Santamaría, A; Sierra, J; Sureda, A | 1 |
| Browne, PV; Daly, PA; Duggan, C; Enright, H; Gardiner, N; Kennedy, MJ; McCann, SR; O'Connell, N | 1 |
2 review(s) available for etoposide and Duncan Disease
| Article | Year |
|---|---|
T-cell post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: another case and a review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Lymphoproliferative Disorders; Male; Multiple Myeloma; Stem Cell Transplantation; T-Lymphocytes | 2004 |
Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
Topics: Adult; Bone Marrow Transplantation; Child; Etoposide; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Lymphoid Tissue; Lymphokines; Lymphoma, T-Cell; Lymphoproliferative Disorders; T-Lymphocytes; Tumor Virus Infections | 1995 |
3 trial(s) available for etoposide and Duncan Disease
| Article | Year |
|---|---|
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Blood Donors; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Melphalan; Middle Aged; Monitoring, Physiologic; Secondary Prevention; Stem Cell Transplantation; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2001 |
Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Hematologic Neoplasms; Humans; Idarubicin; Lymphoproliferative Disorders; Male; Middle Aged | 1998 |
Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2001 |
19 other study(ies) available for etoposide and Duncan Disease
| Article | Year |
|---|---|
Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues.
Topics: Animals; Apoptosis; Autoimmune Diseases; bcl-2-Associated X Protein; Calcium Signaling; Caspases; Cell Membrane Permeability; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Fingolimod Hydrochloride; HeLa Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lymphoproliferative Disorders; Mice; Mice, Knockout; Mitochondria; Mutagenesis; Organ Specificity; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Protein Transport; Receptors, Lysosphingolipid; Sphingolipids; Sphingosine; Spleen; Thymus Gland | 2007 |
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoproliferative Disorders; Organ Transplantation; Postoperative Complications; Prednisone; Prognosis; Retrospective Studies; Vincristine; Young Adult | 2021 |
DA-EPOCH-R for post-transplant lymphoproliferative disorders.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunosuppression Therapy; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2017 |
Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Rituximab; T-Lymphocytes | 2019 |
Are regimens containing rituximab effective in the initial treatment of Epstein-Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis?
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Drug Therapy, Combination; Etoposide; Humans; Immunologic Factors; Immunosuppressive Agents; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Middle Aged; Prednisolone; Rituximab; Time Factors | 2013 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Risk; Steroids | 2015 |
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Carmustine; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoproliferative Disorders; Male; Melphalan; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Rituximab; Vidarabine; Young Adult | 2009 |
Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Crohn Disease; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Glucocorticoids; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Middle Aged; Rituximab | 2009 |
[EBV-associated B-cell lymphoproliferative disorder of the elderly successfully treated with autologous peripheral blood stem cell transplantation and locoregional radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoproliferative Disorders; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2011 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Pilot Projects; Salvage Therapy; Treatment Outcome | 2003 |
Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Lymphoproliferative Disorders; Male; Melphalan; Middle Aged; Salvage Therapy; Transplantation, Autologous; Transplants | 2005 |
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Rituximab; Time Factors; Transplantation Chimera; Transplantation Conditioning; Vincristine; Virus Activation; Whole-Body Irradiation | 2005 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Melphalan; Mesna; Postoperative Complications; Prednisone; Radiotherapy, Adjuvant; Transplantation, Autologous; Vidarabine; Vincristine | 2008 |
Aggressive treatment for postcardiac transplant lymphoproliferation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Life Tables; Lymphoproliferative Disorders; Male; Mechlorethamine; Methotrexate; Middle Aged; Multiple Organ Failure; Postoperative Complications; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Safety, pharmacokinetics, and pharmacodynamics of high-dose etoposide.
Topics: Etoposide; Humans; Infusions, Intravenous; Lymphoproliferative Disorders | 1994 |
Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis.
Topics: Acute Disease; Bone Marrow Transplantation; Child, Preschool; Etoposide; Genetic Linkage; Humans; Infectious Mononucleosis; Lymphoproliferative Disorders; Male; Transplantation, Homologous; X Chromosome | 1994 |
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Count; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Kinetics; Leukapheresis; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Regression Analysis; Salvage Therapy; Time Factors | 2000 |